0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessFurther studies are needed to confirm these preliminary data on safety and efficacy of TV-5010 at a weekly dose of 30 mg.
Nicola De Stefano, Massimo Filippi, Christian Confavreux, Patrick Vermersch, Mihaela Simu, Christian Sindic, Raymond Hupperts, Ovidiu Băjenaru, Gilles Edan, Luigi Grimaldi, Ioan Mărginean, R. Medaer, Giuseppe Orefice, Isabela Pascu, Jean Pelletier, E. A. C. M. Sanders, Elio Scarpini, Gianluigi Mancardi (2008). The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing–remitting multiple sclerosis. , 15(2), DOI: https://doi.org/10.1177/1352458508098269.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2008
Authors
18
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1177/1352458508098269
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
